Overview of Ultracarbon

Property	Description
Active Ingredient	Charcoal, Activated (Medicinal Charcoal)
Form	Oral Tablet (Compressed Powder)
Pharmacological Class	Intestinal Adsorbent
Common Use	Relief of acute Gastrointestinal Upset
Origin	Natural (Carbonaceous Matter)

What Type of Medicine is Ultracarbon?

Ultracarbon is an Over-The-Counter (OTC) pharmaceutical preparation categorized as an Intestinal Adsorbent. Its single active component is Charcoal, Activated. This classification describes the substance’s capacity to function as a physical Detoxifying Agent within the digestive system.

As a proprietary brand, Ultracarbon is typically formulated and marketed by Takeda Pharmaceutical Company across various international markets, establishing it as a highly available choice for consumers. Activated charcoal has a recognized historical and current use as an adsorbent for various substances in the gut.

Composition, Form, and Origin

The active ingredient, Charcoal, Activated (INN), is a highly porous form of carbon prepared through a high-temperature activation process from carbonaceous organic matter such as wood. This processing creates a massive internal surface area that is critical for its function. The drug maintains a standardized pharmaceutical quality, which is essential to ensure consistent binding capacity.

Ultracarbon is presented for oral administration as a solid, compressed powder in the form of an oral tablet. This simple, single-component product ensures the effective delivery of the porous carbon material to the gastrointestinal tract. The medicinal charcoal is not absorbed into the bloodstream; its action is purely local and non-systemic.

What is the General Purpose of an Intestinal Adsorbent?

The general purpose of Ultracarbon is to provide supportive and effective relief of general discomfort caused by acute gastrointestinal issues, such as occasional gas and pressure. It achieves this through the fundamental process of surface adsorption, where the activated carbon physically binds or traps various substances, including certain toxins and excess intestinal gases.

This mechanism aids the body's natural processes by reducing the concentration of compounds that contribute to upset or discomfort. The primary benefit is to assist the body in eliminating irritants.

Regulatory References

Activated Charcoal - StatPearls - NCBI Bookshelf

What side effects are possible with Ultracarbon?

Possible Side Effects and Safety Information

Ultracarbon (Activated Charcoal) functions as a non-systemic intestinal adsorbent, meaning its effects and safety profile are primarily contained within the gastrointestinal tract and it is not absorbed into the bloodstream. Safety information is based on official classifications from regulatory documents.

Officially Documented Adverse Reactions

The most commonly observed effects are directly related to the physical nature of the compound:

Classification	Adverse Reaction	System-Organ Class
Common	Black stools (feces)	Gastrointestinal Disorders
Common	Constipation	Gastrointestinal Disorders

The risk of constipation and, rarely, intestinal obstruction is noted to increase with higher dosages or long-time administration according to regulatory texts.

Serious Safety Considerations and Restrictions

While the compound is non-systemic, official labeling specifies important safety constraints:

Serious Complications: Gastrointestinal obstruction (Ileus) and Pulmonary aspiration are documented as serious, though often rare, adverse reactions, with the latter linked to compromised airway protection.
Contraindications: The medicine is strictly contraindicated in cases of known or suspected intestinal obstruction or significantly decreased intestinal movement (peristalsis).
Drug Interaction Consequence: Due to its powerful adsorbent capacity, Activated Charcoal can reduce the systemic absorption and effectiveness of other orally administered medications, including drugs like oral contraceptives, if taken concurrently.
Population Safety: Use during pregnancy and breastfeeding is generally considered safe for short-term use, given the absence of systemic absorption.

Overdose and Emergency Response

Overdose Manifestations and Severe Outcomes

Because Ultracarbon (Activated Charcoal) is an intestinal adsorbent that is not absorbed into the bloodstream, an overdose does not result in systemic organ toxicity. Instead, regulatory labeling documents the clinical manifestations as local, physical consequences within the gastrointestinal tract.

The primary presentation of excessive ingestion includes mechanical issues such as constipation and severe faecal impaction. More serious outcomes associated with excessive or repeated use include the potential for intestinal obstruction (bowel blockage) and, rarely, intestinal perforation. A noticeable, non-harmful sign is the blackening of the stools.

A life-threatening risk explicitly noted in regulatory information is pulmonary aspiration of the charcoal material, which can lead to airway obstruction, particularly if the substance is administered to a person with an unprotected airway.

When to Seek Immediate Help

In any case of suspected overdose, regulatory authorities state that it is mandatory to contact a poison control center or emergency room at once and seek immediate medical attention. This urgent action is required to address the potential for severe mechanical complications or the risk of aspiration. Hospital monitoring may also be required.

The official treatment strategy involves symptomatic and supportive treatment; regulatory documents confirm that no specific systemic antidote is known for Activated Charcoal.

Therapeutic Uses of Ultracarbon

Relief from Acute Gas, Bloating, and Abdominal Pressure

Ultracarbon is commonly used across conditions presenting with acute episodes involving excess intestinal gas accumulation. It is applied in addressing symptom clusters such as pronounced bloating, flatulence, and feelings of abdominal pressure that may interfere with daily comfort. Activated charcoal is recognized for its role in reducing excessive intestinal gas accumulation and related discomfort. This supportive management may help ease the overall symptom burden, and may contribute to improved comfort during periods of heightened symptoms.

Supportive Management of Non-Severe Diarrhea

The medication is relevant in conditions characterized by episodic or fluctuating manifestations of acute, non-specific diarrhea. It supports the management of symptoms that may appear suddenly, including loose stools and increased frequency of bowel movements. Used in settings where short-term symptomatic assistance is needed, it offers supportive relief that supports the patient during difficult episodes by easing distress. The medication is also applicable in situations of discomfort linked to the likely presence of unwanted irritants following dietary indiscretion.

Quick Fact: Supports Relief for Acute Gas and Diarrheal Discomfort

Eligibility and Restrictions for Use

Who can and cannot use Ultracarbon? — Official Regulatory Information

The eligibility for Ultracarbon (Activated Charcoal) is defined by its physical, non-systemic action in the gastrointestinal (GI) tract. Use is generally permitted for adults and adolescents for its non-severe indications.

Population Status	Regulatory Finding
Populations Contraindicated	Patients with known or suspected intestinal obstruction or paralytic ileus. Patients with a compromised or unprotected airway due to the high risk of aspiration.
Age-Related Eligibility	Use in adults is generally permitted. Minimum age thresholds apply for pediatric use, with limitations frequently specified in national labeling. Use in infants is often not recommended.
Pregnancy and Lactation	Use is permitted / not contraindicated. Regulatory documents confirm this status because the active substance is not absorbed systemically from the gut.
Condition-Specific Restrictions	Conditional use is required for patients who have undergone recent GI surgery or have conditions that increase the risk of GI hemorrhage or perforation. Renal or hepatic impairment is not a contraindication.

Regulatory documents define eligibility primarily through absolute contraindications that address the drug's physical action: patients must have an uncompromised GI tract and a protected airway. The lack of systemic absorption is the basis for permitting its use in pregnancy and during breastfeeding.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official interaction profile of Ultracarbon is defined exclusively by its non-systemic, physical mechanism as an intestinal adsorbent. Since Activated Charcoal is not absorbed into the body, it does not participate in systemic interactions involving metabolic enzymes or drug transporters.

Exposure Modification and Interacting Substances

The primary documented interaction is pharmacokinetic via adsorption. Activated Charcoal physically binds and sequesters other oral substances within the gastrointestinal tract, a process which officially results in a reduction in their systemic absorption. This action reduces the plasma concentration (Cmax/AUC) of co-administered oral medicines, leading to a subsequent loss of their therapeutic efficacy. This exposure-modifying interaction applies broadly to all oral medications, including those subject to enterohepatic recirculation (e.g., Digoxin, Phenytoin), as well as nutritional supplements, vitamins, and minerals.

Mandatory Separation Requirements

To circumvent the risk of reduced efficacy, regulatory documents impose mandatory constraints on the timing of administration. A mandatory separation of at least one to two hours must be maintained between the medicinal charcoal and any other oral medicine. This rule also applies to the consumption of milk or dairy products. Co-administration with certain oral substances, such as Ipecac Syrup, is functionally restricted because the charcoal physically blocks the intended action of the second substance.

Mechanism of Action

Adsorption and Binding in the Gut Lumen

The mechanism of action is non-systemic and entirely physical, targeting various small molecules and compounds present in the gastrointestinal (GI) tract lumen. The active substance possesses a highly porous structure and immense surface area, which enables the physical binding (adsorption) of these molecules and gases. This sequestration is non-specific and occurs through weak intermolecular forces, effectively neutralizing the bound substances. This physical interaction directly results in the physiological consequence of reducing the systemic absorption of these compounds, as the bound complexes are prevented from passing across the intestinal wall.

Interrupting Internal Cycling

The substance also modulates the enterohepatic recirculation pathway. It binds to certain compounds that have already entered the circulation, traveled to the liver, and been excreted back into the gut lumen (e.g., via bile). By capturing these re-released compounds, the mechanism effectively lowers the concentration gradient required for reabsorption. This action engages elimination mechanisms, contributing to the physiological consequence of increased fecal excretion of sequestered compounds. The substance itself is biologically inert and passes through the digestive tract unchanged.

Dosage and Administration Information

Administration Guidelines for Activated Charcoal

Ultracarbon (activated charcoal) use is structured by established parameters, focusing strictly on administration route, timing, and dosage.

Administration Scope	Standard Guideline
Route of Administration	Oral (by mouth) or by intragastric tube (nasogastric or orogastric) under medical supervision.
Standard Single Dose	Adults: 50 to 100 grams. Children (1–12 years): 25 to 50 grams. Infants (<1 year): 1 gram per kg of body weight.
Frequency (MDAC)	For Multiple-Dose Activated Charcoal (MDAC): an initial dose followed by 10 to 25 grams repeated every 2 to 6 hours.

Procedural Requirements

The administration of activated charcoal is time-dependent, with maximum benefit generally achieved when given within one hour of ingestion.

Preparation: If using granules, they must be mixed with water to the indicated volume and shaken thoroughly to form a suspension.
Dosing Separation: Do not administer simultaneously with other oral medications (including oral antidotes or emetics); a separation of at least two hours is typically required.
Airway Protection: Activated charcoal should only be given to unconscious patients when a cuffed endotracheal tube is in place to protect the airway.

Recent Clinical Evidence

Ultracarbon: Overview of Research Studies

Evidence for Use in Acute Gas, Bloating, and Abdominal Pressure

Research has included randomized controlled trials (RCTs) to explore the management of acute gas, bloating, and abdominal discomfort. Studies examined outcomes such as breath hydrogen levels—a marker of intestinal gas—and patient reports of physical discomfort. These trials typically involved adult cohorts and were conducted in limited research scenarios. Findings across various studies have been mixed, which suggests variability in the reported outcomes and highlights a need for further consistency.

Evidence for Supportive Management of Non-Specific Diarrhea

The evidence base where activated charcoal was studied for acute, non-specific diarrhea also includes RCTs. Researchers evaluated outcomes related to bowel function, such as changes in stool frequency and the duration of the acute episode in adult patient cohorts. While one notable randomized trial monitored these measures alongside a placebo, scientific literature indicates that the evidence is limited in quantity for this specific application.

Long-Term Evidence and Research Gaps

The available research focuses almost exclusively on short-term symptom changes, meaning follow-up durations were limited. Consequently, long-term effects are not fully established. Furthermore, the data was observed in adults, and information for certain groups, such as pregnant or older adult populations, remains insufficient. The research base is characterized by generally small sample sizes and a scarcity of large, comparative studies, indicating that certainty remains low in several areas.

Frequently Asked Questions (FAQ)

Common questions about Ultracarbon (FAQ)

Q: How long do the effects of Ultracarbon typically last after taking a dose?

Information from regulatory sources suggests that activated charcoal can remain in the gastrointestinal tract for a significant period. When used alongside a cathartic (a substance that promotes bowel movements), its physical presence can last for about 8 to 12 hours until it is fully excreted. The specific duration of its binding activity for non-emergency uses, such as gas relief, is not routinely specified in official product information.

Q: Is Ultracarbon effective for all types of stomach upset or just diarrhea and gas?

Official information indicates that activated charcoal is used for symptoms such as flatulence, intestinal distention, and general indigestion (dyspepsia). While it has been studied for managing diarrhea, regulatory reviews suggest that its effectiveness in all contexts of diarrhea management has not been definitively established, and it is commonly recognized for use in relieving gas-related discomfort, though it is also studied for other non-specific GI upset.

Q: Why is Ultracarbon sometimes used in cases of poisoning or overdose?

In specific emergency situations, activated charcoal is a recognized measure for gastrointestinal decontamination. This is because its highly porous structure allows it to adsorb (bind to) many ingested toxins and poisons directly within the digestive tract, preventing them from being absorbed into the body and causing systemic harm.

Q: Can Ultracarbon be used by children for common digestive issues like gas or mild diarrhea?

Regulatory guidelines and references do provide dosing information for activated charcoal in children of various age groups. However, the established dosing instructions for children are primarily detailed for the treatment of acute poisoning, and its use for routine, non-severe digestive issues in children is not universally indicated across all official product labels without specific medical guidance.

Q: What scientific evidence supports Ultracarbon's use for general detoxification?

Official medical and governmental health reviews indicate that the use of activated charcoal for general 'detoxification' or 'cleanses' is not supported by rigorous scientific evidence and is considered outside its established medical indications.

Q: Should Ultracarbon be taken with food or on an empty stomach for best results?

Official drug information states that it may be taken with or without food. However, in emergency situations, if a person has ingested a large meal with toxins, official guidance indicates that a larger amount of charcoal may be used.

Q: Does Ultracarbon have an expiration date, and does it lose potency over time?

Yes, like all pharmaceutical products, the Ultracarbon packaging carries an expiration date. Official storage guidelines emphasize that the product remains stable until this date only when it is stored correctly, protected from moisture and heat. The regulatory label does not specifically address 'potency loss' due to improper storage or use after expiration.

Q: Is it possible for Ultracarbon to cause an allergic reaction?

Official safety information advises that patients should be aware of the potential for an allergic reaction, as is possible with any medicine. Patients experiencing signs of a severe allergic reaction, such as hives, difficulty breathing, or swelling of the face, lips, or throat, require immediate medical assessment.

Q: Why do some sources recommend not taking Ultracarbon if you have slowed digestion?

Activated charcoal is strictly contraindicated if there is a known or suspected intestinal obstruction or an absence of active bowel movement (slowed motility). This restriction is due to the potential for the charcoal complex to remain in the gastrointestinal tract, which can increase the risk of serious complications such as intestinal obstruction.

Q: Is there a risk of dehydration associated with using Ultracarbon for diarrhea?

Dehydration is listed as a potential serious side effect, particularly when activated charcoal is administered in a formulation that also contains a cathartic (a substance that promotes bowel movements). Symptoms can include dizziness and feeling very thirsty.

Q: Will Ultracarbon work for diarrhea caused by a virus or 'stomach bug'?

According to established clinical guidelines, activated charcoal is not recommended for the routine treatment of acute gastroenteritis, which is often caused by a virus or 'stomach bug.' In cases of viral diarrhea, the primary medical management typically focuses on effective rehydration.

Q: What are the visible signs that Ultracarbon has passed through my system?

The most common and expected side effect that indicates the charcoal has traveled through and is leaving the digestive system is the presence of black stools (feces). This is an expected physical result due to the presence of the charcoal in the digestive system.

Q: What should I do if I vomit after taking Ultracarbon for acute poisoning?

In the context of acute poisoning, medical guidelines state that if a patient vomits after receiving the initial dose, the dose is typically repeated immediately by a healthcare professional, if clinically feasible.

Q: Is Ultracarbon available in liquid or powder form, or only tablets?

Official reference guides confirm that activated charcoal is produced in several different dosage forms. While Ultracarbon is often marketed as an oral tablet, the active ingredient is also available in forms such as capsules, liquid, powder, pellets, and oral suspensions.

Q: Can Ultracarbon be used to help reduce gas before a medical procedure like an ultrasound?

Yes, official monographs note that activated charcoal has been used in specific instances as part of a bowel preparation regimen. By reducing intestinal gas content, it can help improve the visualization of internal organs during procedures like abdominal radiography or ultrasound.

Q: Are there any specific foods or drinks that should be avoided while taking Ultracarbon?

Official medical guidelines recommend against administering activated charcoal simultaneously with milk. Additionally, a separation of at least two hours is typically required between the charcoal and other oral medications, supplements, or specific foods like milk, to prevent the charcoal from binding and reducing their absorption.

Q: Does Ultracarbon interact with common antidepressant or psychiatric medications?

Yes, due to its physical binding action, activated charcoal can reduce the absorption of many oral medications, including certain psychiatric drugs like antidepressants. This reduction in absorption may lead to decreased therapeutic efficacy of the co-administered medication, necessitating a mandatory separation period between doses.

Q: Is Ultracarbon regulated as a drug or as a supplement?

Ultracarbon is officially classified as an Over-The-Counter (OTC) pharmaceutical preparation and a poison adsorbent, placing it under drug regulation. While the ingredient itself is also sometimes sold in the marketplace as a nutraceutical, Ultracarbon is manufactured and regulated to pharmaceutical standards.

Q: Will Ultracarbon affect the color of my tongue?

According to reports of potential side effects, the ingestion of activated charcoal has been noted to potentially cause a temporary blackening or discoloration of the tongue.

Q: What does 'enteropathic' or 'enterohepatic' recirculation mean in the context of how Ultracarbon works?

Enterohepatic recirculation is a natural bodily process where certain substances (like toxins or drugs) are processed by the liver, excreted into the bile, and then reabsorbed back into the bloodstream from the gut. Activated charcoal interrupts this cycle by binding to these re-released substances in the gut, which promotes their final excretion via feces.

Q: Why is Ultracarbon not effective for poisons like iron or lithium?

Activated charcoal is not a universal antidote. Official monographs specify that it has low or negligible adsorptive capacity for certain substances, including specific molecules like iron salts and lithium. Therefore, it is ineffective as a treatment for poisoning caused by these particular compounds.

Q: Are there different grades of activated charcoal, and is Ultracarbon considered medical-grade?

Activated carbon does exist in various grades. Products intended for medicinal use, such as Ultracarbon, are manufactured to meet the strict quality and purity requirements of the pharmaceutical industry to ensure a consistent and effective binding capacity.

Q: Is there a specific time of day that is better to take Ultracarbon?

Official references note that for the relief of gas and indigestion, the product is often used either immediately before meals or shortly after consuming foods that may cause stomach discomfort.

How should Ultracarbon be stored and disposed of?

How to Store and Dispose of Ultracarbon

The storage of Ultracarbon (activated charcoal tablets) must align strictly with regulatory mandates to preserve its stability and adsorbent capacity.

Storage Requirements

Condition	Requirement
Temperature	Store at or below 25 C (77 F).
Protection	Keep in the original container and protected from moisture and excessive heat.
Safety	Must be stored out of the sight and reach of children.

The product's stability is maintained until the expiration date only when these conditions are observed. The container should be tightly closed to prevent environmental exposure.

Disposal

Disposal of any unused or expired Ultracarbon product must follow local regulatory requirements for medicinal waste. Do not dispose of the tablets via wastewater or household trash unless specifically instructed by local authorities.

Ultracarbon